These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22059937)

  • 21. Levetiracetam: preliminary efficacy in generalized seizures.
    Kasteleijn-Nolst Trenité DG; Hirsch E
    Epileptic Disord; 2003 May; 5 Suppl 1():S39-44. PubMed ID: 12915340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous levetiracetam in children with seizures: a prospective safety study.
    Ng YT; Hastriter EV; Cardenas JF; Khoury EM; Chapman KE
    J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The SKATE study: interim analysis.
    Olwen GO
    Int J Clin Pract; 2003; 57(6):544-5. PubMed ID: 12918896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombocytopenia as an adverse effect of levetiracetam therapy in a child.
    Peer Mohamed B; Prabhakar P
    Neuropediatrics; 2009 Oct; 40(5):243-4. PubMed ID: 20221962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-injury in people with intellectual disability and epilepsy: a matched controlled study.
    Buono S; Scannella F; Palmigiano MB; Elia M; Kerr M; Di Nuovo S
    Seizure; 2012 Apr; 21(3):160-4. PubMed ID: 22244737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chorea in a patient with cerebral palsy: treatment with levetiracetam.
    Recio MV; Hauser RA; Louis ED; Radhashakar H; Sullivan KL; Zesiewicz TA
    Mov Disord; 2005 Jun; 20(6):762-4. PubMed ID: 15747368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of levetiracetam in the treatment of drug-resistant Rett syndrome.
    Specchio N; Balestri M; Striano P; Cilio MR; Nardello R; Patanè S; Margiotta ML; D'Orsi G; Striano S; Russo S; Specchio LM; Cusmai R; Fusco L; Vigevano F
    Epilepsy Res; 2010 Feb; 88(2-3):112-7. PubMed ID: 19914805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levetiracetam in children and adolescents with epilepsy and hemiplegic cerebral palsy.
    Harbord MG
    J Paediatr Child Health; 2011 May; 47(5):302-4. PubMed ID: 21244554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous levetiracetam in the management of acute seizures in children.
    Reiter PD; Huff AD; Knupp KG; Valuck RJ
    Pediatr Neurol; 2010 Aug; 43(2):117-21. PubMed ID: 20610122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptability and tolerability of levetiracetam oral solution for the treatment of partial-onset seizures: the SOLUCIÓN study.
    Matías-Guíu J; Molins A; Mauri JA; Villar E
    Methods Find Exp Clin Pharmacol; 2010 Sep; 32(7):507-16. PubMed ID: 21069102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenging behavior in adults with epilepsy and intellectual disability: An analysis of epilepsy characteristics.
    van Ool JS; Snoeijen-Schouwenaars FM; Tan IY; Jurgen Schelhaas H; Aldenkamp AP; Hendriksen JGM
    Epilepsy Behav; 2018 Sep; 86():72-78. PubMed ID: 30153936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures.
    Schiemann-Delgado J; Yang H; Loge Cde L; Stalvey TJ; Jones J; Legoff D; Mintz M
    J Child Neurol; 2012 Jan; 27(1):80-9. PubMed ID: 21876066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remember Keppra: seizure control with subcutaneous levetiracetam infusion.
    Murray-Brown FL; Stewart A
    BMJ Support Palliat Care; 2016 Mar; 6(1):12-3. PubMed ID: 26811092
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
    Xiao Z; Li JM; Wang XF; Xiao F; Xi ZQ; Lv Y; Sun HB
    Eur Neurol; 2009; 61(4):233-9. PubMed ID: 19176965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levetiracetam for seizures in children with brain tumors and other cancers.
    Partap S; Fisher PG
    Pediatr Blood Cancer; 2009 Feb; 52(2):288-9. PubMed ID: 18831033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levetiracetam in a neonate with malignant migrating partial seizures.
    Hmaimess G; Kadhim H; Nassogne MC; Bonnier C; van Rijckevorsel K
    Pediatr Neurol; 2006 Jan; 34(1):55-9. PubMed ID: 16376281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self injurious behavior in temporal lobe epilepsy.
    Shakya DR; Shyangwa PM; Pandey AK; Subedi S; Yadav S
    JNMA J Nepal Med Assoc; 2010; 49(179):239-42. PubMed ID: 22049832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of levetiracetam in hemifacial spasm: a case report.
    Biagio Carrieri P; Petracca M; Montella S
    Clin Neuropharmacol; 2008; 31(3):187-8. PubMed ID: 18520988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risperidone in young children with pervasive developmental disorders and other developmental disabilities.
    Demb HB
    J Child Adolesc Psychopharmacol; 1996; 6(1):79-80. PubMed ID: 9231302
    [No Abstract]   [Full Text] [Related]  

  • 40. Levetiracetam in continuous spike waves during slow-wave sleep syndrome.
    Wang SB; Weng WC; Fan PC; Lee WT
    Pediatr Neurol; 2008 Aug; 39(2):85-90. PubMed ID: 18639750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.